Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 28Kisspeptin (KP-10) literatureVirulence · Observational2026

Virulence attenuation in ST11-K64 Klebsiella pneumoniae explains its divergent clinical manifestation from ST23-K1.

ST11-K64 Klebsiella pneumoniae shows reduced lethality and impaired ability to cause severe infections compared to ST23-K1, indicating different clinical implications for these strains.

Read at VirulenceAdd to compare

Where it sits

this study against the rest of the kisspeptin (kp-10) corpus
1
Preclinical
23
Observational · this one
0
Open-label
3
Randomised
1
Reviews

Summary and findings

The study measured the pathogenicity differences between ST11-K64 and ST23-K1 strains of Klebsiella pneumoniae. Among 847 clinical isolates, 157 (18.5%) were identified as hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKP). The ST11-K64 clone showed significantly attenuated lethality in mouse models compared to ST23-K1.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
157 (18.5%) of 847 clinical Klebsiella pneumoniae isolates were identified as hv-CRKP.2026

Abstract

The authors’ words, as Virulence supplied them

The clinical threat posed by Klebsiella pneumoniae is dual-faceted, encompassing both hypervirulence and carbapenem resistance. The emergence of hypervirulent carbapenem-resistant K. pneumoniae (hv-CRKP) merges these threats, with the ST11-K64 clone being a dominant and concerning lineage. However, its clinical presentation diverges from the classic hypervirulent Klebsiella pneumoniae (hvKp); hv-CRKP is isolated from respiratory sites but is notably absent from pyogenic liver abscesses. This distinct clinical niche prompted us to investigate the underlying pathogenicity differences. Among 847 clinical Klebsiella pneumoniae isolates, 157 (18.5%) were identified as hv-CRKP. From this hv-CRKP collection, we selected five representative ST11-K64 isolates for downstream phenotypic and mechanistic analyses. Despite its prevalence and multidrug resistance, the ST11-K64 clone exhibited significantly attenuated lethality in mouse models compared to ST23-K1. Crucially, in a murine intestinal colonization model that mimics natural infection, only ST23-K1 successfully colonized the gut, caused bacteremia, and formed liver abscesses. In contrast, ST11-K64 strains showed impaired intestinal colonization and failed to translocate to the liver. Phenotypic profiling showed reduced capsule viscosity and siderophore production in ST11-K64 relative to ST23-K1, accompanied by diminished macrophage and Kupffer cell-associated fitness. RT-qPCR identified higher expression of rmpA, rmpA2, iroB, and iucA in ST23-K1, and isogenic deletion and complementation of rmpA2 or iucA in the ST23-K1 background supported their contribution to capsule/siderophore-associated phenotypes and intracellular survival in RAW264.7 macrophages. Together, these results indicate that while ST11-K64 hv-CRKP represents a serious antimicrobial-resistance threat, its invasive pathogenicity is route- and context-dependent and does not fully recapitulate the classic entero-hepatic hypervirulence of ST23-K1.

Elsewhere in the Kisspeptin (KP-10) corpus

CRegulation of PACAP gene expression by ovarian sex steroids and kisspeptin: Study using hypothalamic cell lines and an <i>in vivo</i> female rat model.Biochemistry and biophysics reports · 2026 · 100 nM PACAP significantly increased Kiss-1 gene expression in all three hypothalamic cell lines.AnimalCKisspeptin-10 alleviates OGD/R-induced H9c2 cardiomyocyte injury by triggering autophagy via regulating the YY1/TFEB axis.Cytotechnology · 2023 · Not reported in abstract.In vitroCKiss1 neurons in the medial amygdala of mice are sexually dimorphic and unique from hypothalamic anteroventral periventricular Kiss1 neurons in their action potential firing propertiesbiorxiv-preprint · 2026 · Not reported in abstract.AnimalBDifferentiation of KISS1-Expressing Cells from Human Pluripotent Stem Cells: Many Roads To Romebiorxiv-preprint · 2026 · Not reported in abstract.In vitroBClinical immunogenicity and pharmacokinetic assessments of E3112, a recombinant human hepatocyte growth factor.Future science OA · 2026 · Half-life of 19.3 h.HumanCT cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.Animal